Planta Med 1999; 65(8): 704-708
DOI: 10.1055/s-1999-14046
Original Paper

Georg Thieme Verlag Stuttgart · New York

Anti-Inflammatory Activities of Hypocretenolides from Leontodon hispidus

Christian Zidorn1 , Verena  M. Dirsch2 , Peter Rüngeler3 , Silvio Sosa4 , Roberto Della Loggia4 , Irmgard Merfort3 , Heike  L. Pahl5 , Angelika  M. Vollmar3 , Hermann Stuppner1
  • 1 Institut für Pharmakognosie, Leopold-Franzens-Universität, Innsbruck, Austria
  • 2 Institut für Pharmazie, Zentrum für Pharmaforschung, Ludwig-Maximilians-Universität, München, Germany
  • 3 Institut für Pharmazeutische Biologie, Albert-Ludwigs-Universität, Freiburg, Germany
  • 4 DEMREP, Università di Trieste, Trieste, Italy
  • 5 Experimentelle Anästhesiologie, Universitätsklinik, Freiburg, Germany
Further Information

Publication History

February 1, 1999

May 22, 1999

Publication Date:
31 December 1999 (online)

Abstract

Hypocretenolides, a small group of sesquiterpene lactones with an unusual ring structure, are constituents of a small number of species from the Lactuceae tribe (Asteraceae). Three biogenetically closely related 14-hypocretenolides from Leontodon hispidus L. were investigated for a putative anti-inflammatory activity. 14-Hydroxyhypocretenolide-β-D-glucoside-4′-14″-hydroxyhypocretenoate significantly exhibited in vivo anti-inflammatory activity in the croton oil-induced mouse ear edema. To obtain first information regarding the molecular targets which might be affected by this constituent, two in vitro bioassays were performed: (i) DNA binding activity of the transcription factor NF-κB was evaluated by electrophoretic mobility shift assay (EMSA) using TNF-α-activated Jurkat T cells and (ii) nitrite accumulation in cell culture supernatants of LPS-activated RAW 264.7 macrophages was determined as a parameter for inducible nitric oxide synthase (iNOS)-dependent nitric oxide release. In order to gain information about structure-activity relationships, additionally the aglycone 14-hydroxyhypocretenolide and its D-glycoside were investigated in these in vitro systems. 14-Hydroxyhypocretenolide-β-D-glucoside-4′-14″-hydroxyhypocretenoate as well as its aglycone exhibited activity in both test systems, whereas the D-glucoside was not or only weakly active.